SALT LAKE CITY, May 28, 2020 (GLOBE NEWSWIRE) — Myriad Genetics, Inc. (NASDAQ: MYGN), a global leader in molecular diagnostics and […]
Fort Lauderdale , May 28, 2020 (GLOBE NEWSWIRE) — As an innovator in tech and ingenuity Elon Musk has no equal, […]
NEW YORK, May 28, 2020 (GLOBE NEWSWIRE) — Seelos Therapeutics, Inc. (Nasdaq: SEEL), a clinical-stage biopharmaceutical company focused on the development […]
LEXINGTON, Mass., May 28, 2020 (GLOBE NEWSWIRE) — Keros Therapeutics, Inc. (“Keros”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on the […]
MOUNTAIN VIEW, Calif., May 28, 2020 (GLOBE NEWSWIRE) — IGM Biosciences, Inc. (Nasdaq: IGMS), a clinical-stage biotechnology company focused on creating […]
Results from the ongoing, open-label extension (OLE) study of the pivotal NEURO-TTR trial published in the European Journal of Neurology show […]
WALTHAM, Mass., May 28, 2020 (GLOBE NEWSWIRE) — Apellis Pharmaceuticals, Inc. (Nasdaq: APLS), a global biopharmaceutical company pioneering targeted C3 therapies, today […]
BOSTON, May 28, 2020 (GLOBE NEWSWIRE) — resTORbio (Nasdaq: TORC) today announced the initiation of a randomized, double-blind, placebo-controlled trial of […]
CHICAGO and VANCOUVER, British Columba, May 28, 2020 (GLOBE NEWSWIRE) — Green Thumb Industries Inc. (“Green Thumb”), a leading national cannabis […]
Company to Initiate Multicenter, Placebo-controlled, Randomized Study in JuneTop-line Data Anticipated in Fourth Quarter 2020ROCKVILLE, Md., May 28, 2020 (GLOBE NEWSWIRE) […]